Hi Franklin community,
We’ve got exciting news to share — Franklin is now officially joining the QIAGEN family!
At the heart of this acquisition is our shared commitment to advancing precision medicine. Franklin, our flagship AI-powered interpretation platform, will continue to operate as it always has — with the same team, the same mission, and the same dedication to you, our users.
And most importantly: Franklin isn’t going anywhere — it’s only getting better.
Why we’re excited
This partnership reflects our ongoing mission: to make genomic data more accessible, accurate, and actionable. With QIAGEN’s global reach and scientific leadership, Franklin will be empowered to scale faster, serve more users, and help deliver even greater impact for patients and providers alike.
What this means for you
This new chapter brings meaningful benefits — and no disruptions:
Franklin remains fully operational and independent, just now with even stronger support.
Your experience won’t change — your data, workflows, and platform access stay the same.
Powerful new integrations are coming. With access to QIAGEN’s world-class resources — including HGMD, COSMIC, and QIAGEN’s expert curation teams — Franklin will gain deeper interpretive power and greater scalability.
Franklin now combines AI-driven analysis with QIAGEN’s gold-standard data, enhancing both interpretive depth and diagnostic precision.
This strengthens our ability to serve you. Together, we’re better positioned to innovate, grow, and support the evolving needs of clinical labs and genomics hubs around the world.
What’s next?
In short — nothing changes for you today. But exciting improvements are ahead.
This is not a shift in direction — it’s an acceleration of everything we’ve been building together.
We are deeply grateful for your continued trust and support, and we look forward to sharing more with you soon.